⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JSPR News
Jasper Therapeutics, Inc. Common Stock
JSPR DEADLINE: Faruqi & Faruqi Reminds Jasper Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 18 , 2025 - JSPR
prnewswire.com
JSPR
Class Action Litigation Now Underway by Pomerantz LLP Against Jasper Therapeutics, Inc. – JSPR
accessnewswire.com
JSPR
JSPR Shareholders Have Opportunity to Lead Jasper Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
accessnewswire.com
JSPR
JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
prnewswire.com
JSPR
Jasper Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - JSPR
prnewswire.com
JSPR
Jasper Therapeutics, Inc. (JSPR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
prnewswire.com
JSPR
Lifshitz Law PLLC Announces Investigations of V.F. Corporation (NYSE:VFC), Fluor Corporation (NYSE:FLR), Cytokinetics, Incorporated (NASDAQ:CYTK), And Jasper Therapeutics, Inc. (NASDAQ:JSPR)
accessnewswire.com
VFC
FLR
CYTK
JSPR
Class Action Litigation Filed by Pomerantz LLP for Investors of Jasper Therapeutics, Inc. – JSPR
accessnewswire.com
JSPR
JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
accessnewswire.com
JSPR
JSPR Class Action Notice: Investors with Large Losses Should Contact Robbins LLP for Information on Leading the Jasper Therapeutics, Inc. Class Action
accessnewswire.com
JSPR